Korcegez 2017.

Study characteristics
Methods	Effect of a pharmacist‐led program on improving outcomes in patients with type 2 diabetes mellitus from northern Cyprus: a randomized controlled trial RCT (NA clusters and NA providers), conducted in 1) a 186‐bed public hospital’s outpatient diabetes clinic in Gazimagusa, Northern Cyprus. 2) There were 2 nurses and 5 physicians (in rotation during week days) providing service to 30 patients a day at the outpatient diabetes clinic. A research clinical pharmacist worked 3 hours per day during weekdays at the outpatient diabetes clinic. In Cyprus. 2 arms: 1. Control (standard care) (control arm) and 2. Intervention (pharmacist care) (intervention arm)
Participants	Control arm N: 80 Intervention arm N: 79, NA, NA Diabetes type: 2 Mean age: 62.01 ± 7.3 % Male: 24.37 Longest follow‐up: 12 months
Interventions	Control arm: (standard care) Intervention arm: (pharmacist care) 1) Case management 2) Team change 3) Patient education 4) Promotion of self‐management
Outcomes	Glycated haemoglobin Systolic blood pressure Diastolic blood pressure Low‐density lipoprotein
Funding source	This study was conducted as a PhD thesis by Korcegez under the supervision of Sancar for the clinical pharmacy program at Near East University, Health Sciences Institute, Northern Cyprus, and received no external funding.
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	High risk	Eligible patients were randomised to each group using the registration number.
Allocation concealment (selection bias)	Unclear risk	Not reported.
Patient's baseline characteristics (selection bias)	Low risk	Table 1. P values provided and greater than 0.05 for characteristics.
Patient's baseline outcomes (selection bias)	Low risk	Table 1. Outcomes look balanced between groups.
Incomplete outcome data (attrition bias)	Low risk	3/80 lost in control group (4%), 4/79 lost in intervention group (5%), reasons provided.
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias)	Low risk	Objectively measured outcomes: HbA1c, BP, LDL.
Selective reporting (reporting bias)	Unclear risk	No registered protocol available, however all outcomes in methods are reported in results.
Risk of contamination (other bias)	Low risk	Some cross‐contamination between participants in the usual care and intervention groups might also have occurred because the participants were attending the same outpatient diabetes clinic, which was located in a small community where many residents have close relationships.
Other bias	Low risk	No evidence of other bias.